This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AstraZeneca PLC (AZN)

NYSE: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 0.00 0.00 0.00 0.00
Operating Gains/Losses -961.00M 0.00 0.00 0.00
Extraordinary Gains / Losses n.a. 0.00 0.00 0.00
(Increase) Decrease In Receivables n.a. 311.00M -383.00M 755.00M
(Increase) Decrease in Inventories n.a. 108.00M 135.00M -150.00M
(Increase) Decrease In Other Current Assets n.a. 0.00 0.00 0.00
(Decrease) Increase In Payables n.a. 2.09B 414.00M -1.31B
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital -49.00M 0.00 0.00 0.00
Other Non-Cash Items 1.48B 1.27B 2.65B 5.14B
Net Cash From Continuing Operations 3.32B 7.06B 7.40B 6.95B
Net Cash From Discontinued Operations n.a. 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 3.32B 7.06B 7.40B 6.95B
Sale of Property, Plant & Equipment 1.18B 158.00M 104.00M 199.00M
Cash Used for Investing Activities
Sale of Short-Term Investments n.a. 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -2.79B -2.75B -2.06B -4.62B
Acquisitions -2.45B -3.87B -1.16B -1.19B
Purchases of Short-Term Investments n.a. 0.00 0.00 0.00
Other Cash from Investing Activities -173.00M -493.00M 276.00M 3.75B
Cash Provided by Financing Activities
Net Cash From Investing Activities -4.24B -7.03B -2.89B -1.86B
Issuance of Debt 5.93B 919.00M 0.00 1.98B
Cash Used for Financing Activities
Issuance of Capital Stock 43.00M 279.00M 482.00M 429.00M
Repayment of Long-Term Debt -884.00M -786.00M -27.00M -1.77B
Repurchase of Capital Stock 0.00 0.00 0.00 -2.63B
Payment of Cash Dividends -3.49B -3.52B -3.46B -3.67B
Other Financing Charges, Net -723.00M 404.00M -41.00M 735.00M
Net Cash From Financing Activities 878.00M -2.71B -3.05B -4.92B
Effect of Exchange Rate Changes -76.00M -152.00M -65.00M -4.00M
Net Change in Cash & Cash Equivalents -113.00M -2.83B 1.40B 162.00M
AZN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for AZN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 2 3
Moderate Buy 0 0 0 0
Hold 3 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1
GET AZN ANALYST REPORT

AZN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs